2 ASX 200 shares I'd want to receive as a present today

Merry Christmas! Are there any stocks under your tree?

| More on:
A happy man and woman on a computer at Christmas, indicating a positive trend for retail shares.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I hope everyone who celebrates today is having a wonderful, festive start to their day. Did you receive a pair of socks today? What about a pair of stocks? Receiving S&P/ASX 200 Index (ASX: XJO) shares as a gift is probably not the most popular present, but I'd love it.

Wouldn't it be great to receive a present that gives you cash year after year, and the gift (hopefully) becomes more and more valuable as time goes on?

If I could choose what ASX 200 shares I receive as a present, that'd mean I don't have to pay for them myself or worry about their valuation. It could be fun to receive some of the most exciting ASX 200 shares as a present, which have exceptionally high price-earnings (P/E) ratios.

I'd happily receive some shares of the below two businesses.

Pro Medicus Ltd (ASX: PME)

Pro Medicus may well be the best ASX 200 share out there. Not only does it have enormous profit margins, but its revenue and profit growth outlook is very impressive.

This company describes itself as a leading healthcare informatics business, providing a full range of medical imaging software and services to hospitals, imaging centres, and healthcare groups worldwide. It claims to offer one of the most comprehensive end-to-end offerings in healthcare imaging.

Pro Medicus' operating profit (EBIT) margin is over 60%, one of the highest on the ASX. Any new revenue can also significantly increase the net profit after tax (NPAT).

It's regularly winning new contracts – earlier this week, it announced a A$30 million, 7-year deal with Duly Health and Care, the largest independent, multi-specialty physician-directed medical group in the Midwest USA.

If it continues winning contracts, then the outlook will keep improving.

Why do I want it as a present rather than buying it myself? According to the forecast on Commsec, the ASX 200 share is valued at close to 235x FY25's estimated earnings.

That's an astonishingly high price-earnings (P/E) ratio. But, if there were one business on the ASX to say it's justified, I'd say it's this one.

TechnologyOne Ltd (ASX: TNE)

In my books, TechnologyOne is another of the most impressive companies on the ASX. It claims to be Australia's largest enterprise software company, with locations across six countries. Its main offering is a global software as a service (SaaS) enterprise resource planning (ERP) solution that transforms business. Its customer base includes more than 1,300 leading corporations, government agencies, local councils, and universities.

When I consider the appeal of an ASX growth share, I ask myself an important question: How big can the business' operations/profit become in five or ten years?

The more a business can grow, the more likely it is to deliver pleasing shareholder returns.

The company's long-term target is to reach at least $1 billion of annual recurring revenue (ARR) by FY30, thanks to a combination of a high loyalty rate and strong growth. When the company reported its FY24 result, it said its total ARR was $470.2 million.

It's aiming to achieve revenue growth of at least 15% from its existing customer base each year as customers take up more of the ASX 200 share's products and modules. The average ARR from customers has grown from $100,000 in FY12 to almost $400,000 in FY24.

The company is aiming to reach a profit before tax (PBT) margin of 35% in the coming years, up from 30% in FY24.

Overall, I think this business has a lot of growth potential, and I'd love to be gifted some of its shares and financially contribute to its success.

According to the forecasts on Commsec, the TechnologyOne share price is valued at 75x FY25's estimated earnings.

Should you invest $1,000 in Pro Medicus right now?

Before you buy Pro Medicus shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Pro Medicus wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 3 April 2025

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A happy youngster holds a giant bag of carrots at a supermarket fruit and vegie section, indicating savings made by buying in bulk.
Opinions

Are these the best US stocks to consider buying right now?

I think these stocks would do well in any portfolio today.

Read more »

Woman and man calculating a dividend yield.
Opinions

This ASX 300 share is near a 52-week low, is it time to buy?

Is this stock an underrated opportunity to buy?

Read more »

A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
Opinions

If I were in my 20s, I'd buy these ASX shares

These stocks offer compelling growth potential.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Opinions

2 great ASX growth shares that are much cheaper after the market sell-off

These stocks are growing earnings and have much better valuations.

Read more »

Woman thinking in a supermarket.
Opinions

The pros and cons of buying Woolworths shares right now

Should investors put Woolworths shares in their stock basket?

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Opinions

Why I think this ASX small-cap stock is a bargain at $3.85

I’m excited about the potential of this rapidly-growing business.

Read more »

A female executive smiles as she carries out business on her mobile phone.
Opinions

Recession ASX stocks are back: Consider buying the dip this April

I think this is a great time to buy stocks.

Read more »

Group of successful real estate agents standing in building and looking at tablet.
Opinions

Here are Macquarie's top 3 stock picks in the ASX financial share sector in April

Macquarie is bullish about these three financial stocks.

Read more »